Health
UCLH doses first patient in the world in Covid-19 antibody trial – University College London Hospitals
UCLH has opened a new vaccine research centre with two clinical trials testing a long-acting antibody combination treatment to protect against Covid-19.
UCLH has opened a new vaccine research centre with two clinical trials testing a long-acting antibody combination treatment to protect against Covid-19.
Researchers in the STORM CHASER study led by UCLH virologist Dr Catherine Houlihan recruited the first participant in the world to the study earlier this month and have recruited 10 participants to date.
They believe the antibody or LAAB, known as AZD7442 and developed by AstraZeneca, may offer immediate and long-term protection to people who have…
-
Noosa News17 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
Noosa News18 hours agoForum responds to urgent homelessness issues in Nambour
-
General17 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers
-
General20 hours agoFirst home buyers score early access to deposit scheme